AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2021
Aug 2, 2021
29821_dirs_2021-08-02_8a876041-6bce-4060-83ef-83f373e77723.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-07-27
Reporting Person: Butcher Arthur C (EVP&Pres, Asia Pacific)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-27 | Common Stock | S | 9673.0000 | $45.0002 | Disposed | 25749.0000 | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at $45.00 and $45.02. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. On July 27, 2021, the reporting person filed a Form 4 which inadvertently misreported the average sale price of the transactions. In fact, as reported in this amendment, the average sale price was $45.0002.